---
created: 2025-04-13
updated: 2025-04-13T10:53
id: JO>Xx=-Z_u
specialty: pharmaco
specialty_id: 520
tags:
  - source/ak-original-decks::step-1::zanki-pharmacology
  - "source/ak-step1-v11:": 
  - theme/b&b::13-infectious-disease::03-antibiotics::04-protein-synthesis-inhibitors
  - "source/ak-step1-v11:": 
  - theme/firstaid::03-microbiology::07-antimicrobials::14-tigecycline
  - "source/ak-step1-v11:": 
  - source/ome-banner::clinical::06-infectious-disease
  - "source/ak-step1-v11:": 
  - theme/physeo::09-pharm::05-antibiotics::11-tetracyclines
  - "source/ak-step1-v11:": 
  - theme/physeo::09-pharm::05-antibiotics::12-glycylcyclines
  - "source/ak-step1-v11:": 
  - theme/pixorize::04-micro::01-antibiotics-antiparasitics::tigecycline
  - "source/ak-step1-v11:": 
  - theme/sketchypharm::07-antimicrobials::02-inhibitors-of-bacterial-protein-synthesis::01-tetracyclines::zanki-extra
  - source/ak-step1-v11::^other::^expn
  - source/ak-step1-v11::^other::^fa-updates::fa2018
  - source/ak-step1-v11::^other::^highyield::3-highyield-temporary"
type: flashcard
---

# Question
Tigecycline is primarily used for bacteria that are **multiple-drug resistant**

---

# Answer
Has broad spectrum anaerobic, gram negative (E. coli) and positive (MRSA / VRE) coverage